Revenue remained stable year-over-year, but net profit fell 13.77% and operating cash flow turned negative. R&D spending dropped sharply, and credit impairment losses increased, while total assets grew modestly.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.